1.Effects of Zuogui Pill on Gene Expression Profile of Regenerate Hepatic Tissue in MSG-Liver Regeneration-Rat
Hanmin LI ; Xiang GAO ; Misi ZHOU ;
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(02):-
Objective: To research the effects of Zuogui Pill on the gene expression profile of regenerate hepatic tissue in MSG-liver regeneration-rat.Methods: MSG-liver regeneration-rat models were copied;therapy group were given Zuogui Pill(5g/kg) by intragastric administration.Rats were executed at the 5th day after operation,and the regenerate liver tissues were frozen by liquid nitrogen.1176 gene chips of gene expression profile correlated to cell differentiation and multiplication were adopted to observe the changes of gene expression profile in the regenerate liver tissues.Results: There were 292 differential expression genes in therapy group compared with model group(20 genes were up-regulation expressed and 272 genes were down regulation expressed).Conclusion: Zuogui Pill has significant effects on the gene expression profile of regenerate hepatic tissue in MSG-liver regeneration-rat,and most of the genes are down regulation expressed.The result hints that Zuogui Pill could influence the liver regeneration by regulating the gene expressions of MSG-live regeneration-rat.Down regulation of the gene expressions of regenerate hepatic tissue in MSG-liver regeneration-rat possibly is one of the important molecular mechanisms of Zuogui Pill in nourishing liver and kidney.
2.Molecular epidemiological study on human metapneumovirus infection among children in Guangzhou
Jiayu ZHONG ; Bing ZHUB ; Li DENG ; Mingxiu ZHOU ; Yi CHEN ; Jiahui XIE ; Yingying ZHANG ; Lu KUANG ; Misi XIAO
Chinese Journal of Clinical Infectious Diseases 2011;04(4):223-226
ObjectiveTo conduct a molecular epidemiological study on human metapneumovirus (hMPV) among pediatric patients in Guangzhou. MethodsA total of 1 840 clinical specimens were obtained from pediatric patients with respiratory infections in Guangzhou Women and Children' s Medical Center in 2010.hMPV was detected by real-time TaqMan RT-PCR in clinical specimens.F gene was amplified and the PCR-products were directly sequenced. ResultsIn 1 840 clinical specimens, 66 werehMPV-positive with a positive rate of 3.59%. hMPV was detected in all specimens except those collected in September and October, and the highest positive hMPV rate occurred in April (6.09%). The F genes of 3 randomly selected strains and hMPVgz01 ( isolated in 2008) were compared with subgroups A1, A2, B1,B2 and C, and the highest homology was with BJ1887 strain of genotype A2b (97%). The F genes of the randomly selected strains and hMPVgz01 were 99% identical to each other. Sequences and phylogenetics analysis revealed that the epidemical strain in Guangzhou belonged to genotype A2b. ConclusionhMPV is prevalent in spring and summer among children in Guangzhou, and A2b is the predominant genotype.
3.Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103)
Misi HE ; Mingfang GUO ; Qi ZHOU ; Ying TANG ; Lin ZHONG ; Qing LIU ; Xiaomei FAN ; Xiwa ZHAO ; Xiang ZHANG ; Gang CHEN ; Yuanming SHEN ; Qin XU ; Xiaojun CHEN ; Yuancheng LI ; Dongling ZOU
Journal of Gynecologic Oncology 2023;34(3):e55-
Background:
Cervical cancer is still present a major public health problem, especially in developing countries. In International Federation of Gynaecology and Obstetrics 2018, allowing assessment of retroperitoneal lymph nodes by imaging and/or pathological findings and, if deemed metastatic, the case is designated as stage IIIC (with r and p notations). Patients with lymph node metastases have lower overall survival (OS), progression free survival (PFS), and survival after recurrence, especially those who have unresectable macroscopical positive lymph nodes. Retrospective analysis suggests that there may be a benefit to debulking macroscopic nodes that would be otherwise difficult to sterilize with standard doses of radiation therapy. However, there are no prospective study reporting that resecting macroscopic nodes before concurrent chemoradiation therapy (CCRT) would improve PFS or OS of cervical cancer and no guidelines for surgical resection of bulky lymph nodes. The CQGOG0103 study is a prospective, multicenter and randomized controlled trial (RCT) evaluating lymph node dissection on stage IIICr of cervical cancer.
Methods
Eligible patients are histologically confirmed cervical squamous cell carcinoma, adenocarcinoma, adeno-squamous cell carcinoma. Stage IIICr (confirmed by computed tomography [CT]/magnetic resonance imaging/positron emission tomography/CT) and the short diameter of image-positive lymph node ≥15 mm. 452 patients will be equally randomized to receive either CCRT (pelvic external-beam radiotherapy [EBRT]/extended-field EBRT + cisplatin [40 mg/m2] or carboplatin [the area under curve=2] every week for 5 cycles + brachytherapy) or open/minimally invasive pelvic and para-aortic lymph node dissection followed by CCRT. Randomization is stratified by status of para-aortic lymph node. The primary endpoint is PFS. Secondary endpoints are OS and surgical complications. A total of 452 patients will be enrolled from multiple hospitals in China within 4 years and followed up for 5 years.
4.Genetic analysis of cervical cancer with lymph node metastasis
Hao HE ; Misi HE ; Qi ZHOU ; Ying TANG ; Jing WANG ; Xiuying LI ; Dongling ZOU
Journal of Gynecologic Oncology 2024;35(6):e102-
Objective:
To find out the differences in gene characteristics between cervical cancer patients with and without lymph node metastasis, and to provide reference for therapy.
Methods:
From January 2018 to June 2022, recurrent cervical cancer patients 39 cases with lymph node metastasis and 73 cases without lymph node metastasis underwent testing of 1,021 cancer-related genes by next-generation sequencing. Maftools software was used to analyze somatic single nucleotide/insertion-deletion variation mutation, co-occurring mutation, cosmic mutation characteristics, oncogenic signaling pathways.
Results:
EP300 and FBXW7 were significantly enriched in lymph node-positive patients.Lymph node-positive patients with EP300 or FBXW7 mutations had lower overall survival (OS) after recurrence. Both lymph node-positive and -negative patients had plenty of co-occurring mutations but few mutually exclusive mutations. Lymph node-positive cooccurring mutation number ≥6 had lower OS, while lymph node-negative co-occurring mutation number ≥3 had lower OS after recurrence. The etiology of SBS3 was defects in DNA double strand break repair by homologous recombination, which exclusively exist in lymph node-positive patients. There was no difference in median tumor mutation burden (TMB) between positive and negative lymph nodes, but TMB was significantly associated with PIK3CA mutation.
Conclusion
The somatic SNV/Indels of EP300 and FBXW7, SBS3 homologous recombination-mediated DNA repair defect were enriched in lymph node-positive patients.For lymph node-positive patients, EP300 or FBXW7 mutations predicted poor prognosis. No matter lymph node-positive or negative, more co-occurring mutation number predicted poor prognosis. PIK3CA mutation may account for the higher TMB and help identify patients who benefit from immunotherapy.
5.Genetic analysis of cervical cancer with lymph node metastasis
Hao HE ; Misi HE ; Qi ZHOU ; Ying TANG ; Jing WANG ; Xiuying LI ; Dongling ZOU
Journal of Gynecologic Oncology 2024;35(6):e102-
Objective:
To find out the differences in gene characteristics between cervical cancer patients with and without lymph node metastasis, and to provide reference for therapy.
Methods:
From January 2018 to June 2022, recurrent cervical cancer patients 39 cases with lymph node metastasis and 73 cases without lymph node metastasis underwent testing of 1,021 cancer-related genes by next-generation sequencing. Maftools software was used to analyze somatic single nucleotide/insertion-deletion variation mutation, co-occurring mutation, cosmic mutation characteristics, oncogenic signaling pathways.
Results:
EP300 and FBXW7 were significantly enriched in lymph node-positive patients.Lymph node-positive patients with EP300 or FBXW7 mutations had lower overall survival (OS) after recurrence. Both lymph node-positive and -negative patients had plenty of co-occurring mutations but few mutually exclusive mutations. Lymph node-positive cooccurring mutation number ≥6 had lower OS, while lymph node-negative co-occurring mutation number ≥3 had lower OS after recurrence. The etiology of SBS3 was defects in DNA double strand break repair by homologous recombination, which exclusively exist in lymph node-positive patients. There was no difference in median tumor mutation burden (TMB) between positive and negative lymph nodes, but TMB was significantly associated with PIK3CA mutation.
Conclusion
The somatic SNV/Indels of EP300 and FBXW7, SBS3 homologous recombination-mediated DNA repair defect were enriched in lymph node-positive patients.For lymph node-positive patients, EP300 or FBXW7 mutations predicted poor prognosis. No matter lymph node-positive or negative, more co-occurring mutation number predicted poor prognosis. PIK3CA mutation may account for the higher TMB and help identify patients who benefit from immunotherapy.
6.Genetic analysis of cervical cancer with lymph node metastasis
Hao HE ; Misi HE ; Qi ZHOU ; Ying TANG ; Jing WANG ; Xiuying LI ; Dongling ZOU
Journal of Gynecologic Oncology 2024;35(6):e102-
Objective:
To find out the differences in gene characteristics between cervical cancer patients with and without lymph node metastasis, and to provide reference for therapy.
Methods:
From January 2018 to June 2022, recurrent cervical cancer patients 39 cases with lymph node metastasis and 73 cases without lymph node metastasis underwent testing of 1,021 cancer-related genes by next-generation sequencing. Maftools software was used to analyze somatic single nucleotide/insertion-deletion variation mutation, co-occurring mutation, cosmic mutation characteristics, oncogenic signaling pathways.
Results:
EP300 and FBXW7 were significantly enriched in lymph node-positive patients.Lymph node-positive patients with EP300 or FBXW7 mutations had lower overall survival (OS) after recurrence. Both lymph node-positive and -negative patients had plenty of co-occurring mutations but few mutually exclusive mutations. Lymph node-positive cooccurring mutation number ≥6 had lower OS, while lymph node-negative co-occurring mutation number ≥3 had lower OS after recurrence. The etiology of SBS3 was defects in DNA double strand break repair by homologous recombination, which exclusively exist in lymph node-positive patients. There was no difference in median tumor mutation burden (TMB) between positive and negative lymph nodes, but TMB was significantly associated with PIK3CA mutation.
Conclusion
The somatic SNV/Indels of EP300 and FBXW7, SBS3 homologous recombination-mediated DNA repair defect were enriched in lymph node-positive patients.For lymph node-positive patients, EP300 or FBXW7 mutations predicted poor prognosis. No matter lymph node-positive or negative, more co-occurring mutation number predicted poor prognosis. PIK3CA mutation may account for the higher TMB and help identify patients who benefit from immunotherapy.
7.Modified Dingjingtang Regulates TLR2/NF-κB/NLRP3 Signaling Pathway to Alleviate Inflammatory Skin Lesions in Rat Model of Acne
Ying LIU ; Min XIAO ; Misi ZHOU ; Baiyi QIU
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(15):60-68
ObjectiveTo explore the effect and mechanism of modified Dingjingtang in regulating the Toll-like receptor 2 (TLR2)/nuclear factor (NF)-κB/NOD-like receptor protein 3 (NLRP3) signaling pathway to inhibit inflammatory skin lesions in the rat model of acne. MethodsForty-eight rats were randomized into the normal, model, low-, medium-, and high-dose (8.1, 16.2, and 32.4 g·kg-1) modified Dingjingtang, and doxycycline hydrochloride (0.27 g·kg-1) groups, with 8 rats in each group. Rats in other groups except the normal group were modeled by intradermal injection and intraperitoneal injection of Propionibacterium acnes. After successful modeling, rats in the intervention groups were treated with corresponding agents by gavage, and those in the normal and model groups with an equal volume of normal saline, once a day for 14 consecutive days. Then, the samples were collected. The general conditions, ear thickness, and body weight changes of rats were observed. Biochemical methods were used to determine superoxide dismutase (SOD) and malondialdehyde (MDA) levels in the ear tissue. Hematoxylin-eosin staining and Masson's staining were used to observe the pathological changes and collagen deposition, respectively, in the ear tissue. Immunohistochemistry was employed to determine the interleukin (IL)-1β level in the ear tissue. Enzyme-linked immunosorbent assay was adopted to measure the levels of IL-1β, tumor necrosis factor (TNF)-α, and IL-6 in the serum. The total antioxidant capacity method was adopted to assess the reactive oxygen species (ROS) content in the ear tissue. Western blot and real-time fluorescence quantitative polymerase chain reaction were employed to determine the protein and mRNA levels, respectively, of TLR2, myeloid differentiation factor 88 (MyD88), NF-κB, NLRP3, and cysteinyl aspartate-specific proteinase-1 (Caspase-1) in the ear tissue. ResultsCompared with the normal group, the model group had increased ear skin thickness (P<0.01), elevated ROS and MDA levels (P<0.01), reduced SOD content (P<0.05), and increased collagen deposition (P<0.01) in the ear tissue. In addition, the model group showed raised IL-1β, IL-6, and TNF-α levels in the serum (P<0.01) and up-regulated mRNA and protein levels of TLR2, MyD88, NF-κB, NLRP3, and Caspase-1 (P<0.01). Compared with the model group, the high- and medium-dose modified Dingjingtang groups showed significant improving effects regarding the above indicators (P<0.05, P<0.01). ConclusionModified Dingjingtang can ameliorate the inflammatory skin lesions in the rat model of acne by regulating the TLR2/NF-κB/NLRP3 signaling pathway.